$PETS
PETMED EXPRESS INC

2020 Q3 Form 10-Q Financial Statement

#000143774920022358 Filed on November 03, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q3
Revenue $75.44M $69.94M
YoY Change 7.86% -2.04%
Cost Of Revenue $52.42M $49.93M
YoY Change 4.97% 8.22%
Gross Profit $23.02M $20.00M
YoY Change 15.08% -20.8%
Gross Profit Margin 30.51% 28.6%
Selling, General & Admin $11.94M $11.06M
YoY Change 7.96% -3.83%
% of Gross Profit 51.87% 55.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $607.0K $572.0K
YoY Change 6.12% 3.62%
% of Gross Profit 2.64% 2.86%
Operating Expenses $12.55M $11.63M
YoY Change 7.88% -3.49%
Operating Profit $10.47M $8.371M
YoY Change 25.09% -36.6%
Interest Expense $70.00K $460.0K
YoY Change -84.78% 6.98%
% of Operating Profit 0.67% 5.5%
Other Income/Expense, Net $404.0K $763.0K
YoY Change -47.05% 11.71%
Pretax Income $10.88M $9.134M
YoY Change 19.06% -34.22%
Income Tax $2.500M $2.469M
% Of Pretax Income 22.99% 27.03%
Net Earnings $8.412M $6.665M
YoY Change 26.21% -38.01%
Net Earnings / Revenue 11.15% 9.53%
Basic Earnings Per Share $0.42 $0.33
Diluted Earnings Per Share $0.42 $0.33
COMMON SHARES
Basic Shares Outstanding 20.06M 19.96M
Diluted Shares Outstanding 20.15M 19.97M

Balance Sheet

Concept 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $106.3M $94.90M
YoY Change 12.01% 8.96%
Cash & Equivalents $106.3M $94.90M
Short-Term Investments
Other Short-Term Assets $2.600M $2.800M
YoY Change -7.14% 180.0%
Inventory $21.50M $19.10M
Prepaid Expenses
Receivables $2.212M $1.466M
Other Receivables $0.00 $0.00
Total Short-Term Assets $132.6M $118.3M
YoY Change 12.14% -0.72%
LONG-TERM ASSETS
Property, Plant & Equipment $25.47M $26.41M
YoY Change -3.57% -5.95%
Goodwill
YoY Change
Intangibles $860.0K $860.0K
YoY Change 0.0% 0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $26.33M $27.27M
YoY Change -3.46% -5.77%
TOTAL ASSETS
Total Short-Term Assets $132.6M $118.3M
Total Long-Term Assets $26.33M $27.27M
Total Assets $158.9M $145.5M
YoY Change 9.22% -1.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.06M $15.16M
YoY Change 5.96% 6.14%
Accrued Expenses $4.500M $2.900M
YoY Change 55.17% 3.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $21.16M $18.55M
YoY Change 14.07% 8.84%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $21.16M $18.55M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $22.54M $19.95M
YoY Change 13.01% 9.41%
SHAREHOLDERS EQUITY
Retained Earnings $131.1M $123.2M
YoY Change 6.37% 3.6%
Common Stock $20.00K $20.00K
YoY Change 0.0% -4.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $136.4M $125.6M
YoY Change
Total Liabilities & Shareholders Equity $158.9M $145.5M
YoY Change 9.22% -1.71%

Cashflow Statement

Concept 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $8.412M $6.665M
YoY Change 26.21% -38.01%
Depreciation, Depletion And Amortization $607.0K $572.0K
YoY Change 6.12% 3.62%
Cash From Operating Activities $26.39M $17.25M
YoY Change 52.99% -1158.28%
INVESTING ACTIVITIES
Capital Expenditures -$1.040M -$230.0K
YoY Change 352.17% 64.29%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$1.040M -$230.0K
YoY Change 352.17% 64.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.820M -5.530M
YoY Change 5.24% -2.3%
NET CHANGE
Cash From Operating Activities 26.39M 17.25M
Cash From Investing Activities -1.040M -230.0K
Cash From Financing Activities -5.820M -5.530M
Net Change In Cash 19.53M 11.49M
YoY Change 69.97% -254.64%
FREE CASH FLOW
Cash From Operating Activities $26.39M $17.25M
Capital Expenditures -$1.040M -$230.0K
Free Cash Flow $27.43M $17.48M
YoY Change 56.92% -1273.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20272072
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
34000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
59000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3000
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3000
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3000
CY2020Q3 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2020Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20272000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20272000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20166000
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20166000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25136
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
76620
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106344000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103762000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2212000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3843000 USD
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
21451000 USD
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
17884000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2613000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3529000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
132620000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
129018000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25469000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25445000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1026000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
304000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
156000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
338000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000 USD
CY2020Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
26329000 USD
CY2020Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
26305000 USD
CY2020Q3 us-gaap Assets
Assets
158949000 USD
CY2020Q1 us-gaap Assets
Assets
155323000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
16058000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
19658000 USD
CY2020Q3 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
4486000 USD
CY2020Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
4214000 USD
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
618000 USD
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
471000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
21162000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
24343000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1378000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
970000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
22540000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
25313000 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
9000 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
9000 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
20000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
20000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5317000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3804000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
131063000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
126177000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
136409000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
130010000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
158949000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
155323000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
75436000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
69936000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
171640000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
149924000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
52418000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
49934000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
121837000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
108061000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
23018000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
20002000 USD
us-gaap Gross Profit
GrossProfit
49803000 USD
us-gaap Gross Profit
GrossProfit
41863000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6809000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6303000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14563000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12811000 USD
CY2020Q3 us-gaap Advertising Expense
AdvertisingExpense
5131000 USD
CY2019Q3 us-gaap Advertising Expense
AdvertisingExpense
4756000 USD
us-gaap Advertising Expense
AdvertisingExpense
14164000 USD
us-gaap Advertising Expense
AdvertisingExpense
13380000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
607000 USD
CY2019Q3 us-gaap Depreciation
Depreciation
572000 USD
us-gaap Depreciation
Depreciation
1169000 USD
us-gaap Depreciation
Depreciation
1140000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
12547000 USD
CY2019Q3 us-gaap Operating Expenses
OperatingExpenses
11631000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
593000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
561000 USD
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
404000 USD
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
763000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
14532000 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
66000 USD
us-gaap Operating Expenses
OperatingExpenses
29896000 USD
us-gaap Operating Expenses
OperatingExpenses
27331000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
10471000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
8371000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
749000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1587000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10875000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9134000 USD
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
459000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
19907000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20656000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16119000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2463000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2469000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4476000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4111000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
8412000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
6665000 USD
us-gaap Net Income Loss
NetIncomeLoss
16180000 USD
us-gaap Net Income Loss
NetIncomeLoss
12008000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20063000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19963000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20024000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20098000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20154000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19973000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20098000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20109000
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.28
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.27
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.56
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.54
us-gaap Net Income Loss
NetIncomeLoss
16180000 USD
us-gaap Net Income Loss
NetIncomeLoss
12008000 USD
us-gaap Depreciation
Depreciation
1169000 USD
us-gaap Depreciation
Depreciation
1140000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1513000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1365000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
408000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
274000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
61000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
64000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1570000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1012000 USD
us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
3567000 USD
us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
-2309000 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-0 USD
us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-582000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-916000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1433000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3600000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1120000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
391000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
568000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
147000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
525000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15188000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17294000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1193000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
416000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1193000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-416000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11496000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11413000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11014000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11413000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22510000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2582000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5632000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
103762000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
100529000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
106344000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
94897000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
4206000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
2730000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
126000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
155000 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Use of Estimates</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:18pt;">The preparation of Condensed Consolidated Financial Statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
75436000 USD
CY2020Q3 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
69936000 USD
CY2019Q3 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2020Q3 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
5500000 USD
CY2020Q3 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.079 pure
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
75436000 USD
CY2020Q3 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
69936000 USD
CY2019Q3 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2020Q3 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
5500000 USD
CY2020Q3 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.079 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
171640000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
149924000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
21716000 USD
pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.145 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
171640000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
149924000 USD
pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
21716000 USD
pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.145 pure
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
8412000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
6665000 USD
us-gaap Net Income Loss
NetIncomeLoss
16180000 USD
us-gaap Net Income Loss
NetIncomeLoss
12008000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20063000
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19963000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20024000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20098000
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
81000
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
64000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1000
CY2020Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2019Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20154000
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19973000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20098000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20109000
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.42
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.60
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25136
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
76620
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106300000 USD
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
613000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
11500000 USD
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2020Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
28700000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4100000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.226 pure
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.270 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.217 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.255 pure
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
285000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
106000 USD
CY2019Q3 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
322000 USD

Files In Submission

Name View Source Status
0001437749-20-022358-index-headers.html Edgar Link pending
0001437749-20-022358-index.html Edgar Link pending
0001437749-20-022358.txt Edgar Link pending
0001437749-20-022358-xbrl.zip Edgar Link pending
ex_210193.htm Edgar Link pending
ex_210194.htm Edgar Link pending
ex_210195.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pets-20200930.xsd Edgar Link pending
pets-20200930_cal.xml Edgar Link unprocessable
pets-20200930_def.xml Edgar Link unprocessable
pets-20200930_lab.xml Edgar Link unprocessable
pets-20200930_pre.xml Edgar Link unprocessable
pets20200930_10q.htm Edgar Link pending
pets20200930_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending